The Federal Government has announced that consignments of Lenacapavir, a new long-acting HIV prevention drug, are expected to arrive in Nigeria in March 2026. The disclosure was made by the National Agency for the Control of AIDS (NACA) in a statement issued on Monday, March 2, noting that preparations are underway for the introduction and rollout of Lenacapavir (LEN) as pre-exposure prophylaxis (PrEP). Lenacapavir is an injectable HIV prevention option administered twice a year. Clinical trials have shown that the drug significantly reduces the risk of HIV infection and provides near-total protection when properly administered. “The Government of Nigeria (GON) is advancing preparations for the introduction and rollout of Lenacapavir (LEN) as Pre-Exposure Prophylaxis (PrEP). This is par...